Employers are required to provide the hepatitis B vaccination series to any employee with occupational exposure to bloodborne pathogens. This obligation comes from OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030), which mandates that the vaccine be offered at no cost to the employee, during working hours, and within 10 working days of initial assignment to tasks involving exposure. No other bloodborne pathogen vaccine is federally mandated for general occupational exposure.
The hepatitis B requirement is the single vaccination obligation that the federal Bloodborne Pathogens Standard places on employers. The standard does not require hepatitis A, hepatitis C, HIV, or other vaccines, because no licensed vaccines exist for hepatitis C or HIV, and hepatitis A is not transmitted through blood in workplace settings. Understanding what the rule actually requires—and where employers and employees commonly get it wrong—matters for compliance and for worker protection.
How the hepatitis B requirement works
The OSHA standard defines occupational exposure as reasonably anticipated skin, eye, mucous membrane, or parenteral contact with blood or other potentially infectious materials (OPIM) arising from the employee's duties. "Reasonably anticipated" does not require proof that exposure will occur; it means the task carries a recognized potential for it. This distinction matters because employers often wrongly assume that vaccination is required only after a documented exposure incident.
Vaccination must be offered after the employer has identified the employee's exposure risk and provided training, but within 10 working days of initial assignment. The employer covers the full cost of the series and any required follow-up, including titer testing after vaccination when indicated. The employee receives the vaccine during working hours. An employee may decline vaccination by signing a specific declination statement, but that declination can be reversed at any time, and the employer must then provide the vaccine at no cost.
The mechanism behind the requirement is preventive, not reactive. Hepatitis B virus can survive on dried blood and on surfaces for at least seven days, and it is far more infectious than HIV—the virus is transmitted through needlesticks, cuts, splashes to mucous membranes, and contaminated sharps. Post-exposure prophylaxis exists, but pre-exposure vaccination is the primary defense. The standard treats vaccination as a condition of safe assignment, not an optional benefit.
The series is typically three doses given over six months, though the exact schedule depends on the product. Employers cannot require proof of immunity before assignment as a condition of continued employment, but they can require vaccination as a condition of assignment where the standard applies—subject to reasonable accommodation law and the declination option.
Quantified context: exposure risk and the 10-day clock
Hepatitis B is the most frequently transmitted bloodborne pathogen in occupational settings. The CDC estimates that the risk of transmission from a single percutaneous exposure to hepatitis B-positive blood ranges from about 6% to 30% when the source is hepatitis B e-antigen positive, and lower when the source is e-antigen negative. For comparison, the same exposure to HIV carries a transmission risk of roughly 0.3%, and hepatitis C roughly 1.8%. These ranges explain why hepatitis B occupies its own mandate.
The 10-working-day window is a compliance threshold, not a clinical one. OSHA chose it to ensure vaccination begins before sustained exposure accumulates. In practice, a health care employer onboarding a phlebotomist, a dental assistant, or a laboratory worker should schedule the first dose within two weeks of hire. The declination must be documented on the OSHA-specified form, and the employer retains that record for the duration of employment plus the required retention period.
Cost matters at the margin. The three-dose series historically runs from roughly USD 60 to USD 200 per dose depending on the product and setting, and employers bear that cost. This is one reason employers sometimes try to shift vaccination to employees; the standard prohibits that shift for covered employees.
The time course of the requirement
| Stage | Timing | What happens |
|---|---|---|
| Exposure determination | Before assignment | Employer identifies tasks with reasonably anticipated exposure |
| Training and information | At initial assignment | Employee receives Bloodborne Pathogens Standard training |
| Vaccine offer | Within 10 working days of initial assignment | Employer offers the series at no cost, during work hours |
| Dose 1 | As scheduled | First injection; series begins |
| Dose 2 | About 1 month after dose 1 | Second injection per product schedule |
| Dose 3 | About 6 months after dose 1 | Series completed |
| Declination (if any) | At offer | Employee signs declination; may be reversed anytime |
| Post-exposure evaluation | After an exposure incident | Confidential medical evaluation and follow-up |
The time course is not a single event. It is a sequence running from pre-assignment risk determination through series completion, with a separate post-exposure pathway that operates independently of whether the employee was vaccinated.
Edge cases and the counterintuitive detail
The most counterintuitive point is that the mandate is conditional on risk classification, not job title. A custodian who handles regulated waste and contaminated sharps may be covered; a clerical worker in the same building who never handles blood may not be. The employer's written exposure control plan determines coverage, and the classification must be based on actual duties.
Several edge cases create compliance friction:
Employees who previously completed the series may decline revaccination, but the employer should document prior vaccination or immunity where the standard permits it. Employees with a documented medical contraindication to the vaccine are not required to be vaccinated, but the employer must still offer it and document the situation through the health care professional. Employees who decline must sign the declination, but a verbal refusal is not sufficient documentation. Pregnant employees are not exempt; the vaccine is not contraindicated in pregnancy, and the offer still applies. Contract workers and temporary staff may be covered by the host employer's plan or the staffing agency's, depending on who controls the workplace and the exposure. Employers cannot condition employment on vaccination status in a way that conflicts with disability accommodation law, though the standard's declination option already preserves choice.
A professional caveat: the declination form is not a liability shield if the employer failed to properly classify the employee or failed to offer the vaccine within the window. Regulators look at the exposure control plan and the offer documentation, not just the signed form.
Common misconceptions
The most common misconception is that employers must provide "all bloodborne pathogen vaccines." Federal law mandates only hepatitis B for covered employees. There is no licensed hepatitis C vaccine, and HIV vaccination is not a workplace requirement. Hepatitis A vaccination may be recommended in some settings, but it is not part of the Bloodborne Pathogens Standard.
A second misconception is that vaccination is required only after a needlestick. The standard requires the offer before exposure, which is why the 10-day window exists. Post-exposure prophylaxis is a separate obligation triggered by an incident.
A third misconception is that employers can charge employees for the vaccine or require employees to use personal insurance. The standard requires the vaccine at no cost to the employee, and cost cannot be shifted.
A fourth is that a signed declination ends the matter. Employees can request vaccination later, and the employer must provide it at no cost.
Practical actions for employers
Concrete steps reduce both risk and regulatory exposure:
Review the written exposure control plan annually and confirm which job classifications have reasonably anticipated exposure. Offer the hepatitis B series in writing within 10 working days of initial assignment and document the offer date. Schedule the first dose during working hours and cover the full cost, including any titer follow-up. Use the OSHA declination form when an employee refuses, and explain that the decision can be reversed. Retain vaccination and declination records for the required period and make them available to the employee and to regulators on request. Train supervisors on the difference between pre-exposure vaccination and post-exposure evaluation.
Thresholds to reconcile: the 10-working-day offer window, the roughly six-month series completion, and the seven-day survival of hepatitis B on dried surfaces all point in the same direction—early, documented, employer-funded vaccination.
Limitations and what the rule does not cover
The mandate is a floor, not a ceiling. It does not require hepatitis A vaccination, it does not address non-occupational exposure, and it does not guarantee immunity—some vaccinated employees do not develop protective antibody levels and may need additional doses per the health care professional's judgment. The standard also does not resolve conflicts with state law, collective bargaining agreements, or disability accommodation requirements, which can vary by jurisdiction.
The article is general educational information about workplace safety obligations, not a diagnosis, treatment plan, or legal opinion. It does not promise any compliance or health outcome. Readers with specific exposure, vaccination, or compliance questions should consult a qualified occupational health professional or employment attorney in their jurisdiction.